Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET

Go back to Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
(NASDAQ: LTRN) Delayed: 1.71 --0 (-0%)
Previous Close $1.71    52 Week High
Open $1.75    52 Week Low
Day High $1.75    P/E N/A 
Day Low $1.70    EPS
Volume 58,310